Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Menopausal Breast Cancer”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Testing effectiveness (Phase 2)Study completedNCT00259090
What this trial is testing

Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT02238808
What this trial is testing

See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers

Who this might be right for
Estrogen Receptor Positive Breast Cancer
AHS Cancer Control Alberta 19
Early research (Phase 1)Study completedNCT01840488
What this trial is testing

BN83495 Phase I in Post-menopausal Women

Who this might be right for
Breast Cancer
Ipsen 50
Testing effectiveness (Phase 2)Looking for participantsNCT06450873
What this trial is testing

Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery

Who this might be right for
Estrogen Receptor-Positive Breast CarcinomaHER2-Negative Breast Carcinoma
Mayo Clinic 100
Large-scale testing (Phase 3)Study completedNCT00003771
What this trial is testing

Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer

Who this might be right for
Breast CancerMenopausal Symptoms
Regional Oncologic Center 1,300
Testing effectiveness (Phase 2)Study completedNCT04075604
What this trial is testing

Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer

Who this might be right for
Breast CancerCancer
Bristol-Myers Squibb 23
Not applicableEnded earlyNCT01425294
What this trial is testing

Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment

Who this might be right for
Breast Cancer
AstraZeneca 231
Not applicableEnded earlyNCT00555867
What this trial is testing

Patient's Anastrozole Compliance to Therapy Programme

Who this might be right for
Breast Cancer
AstraZeneca 4,923
Testing effectiveness (Phase 2)Study completedNCT00049062
What this trial is testing

Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The University of Texas Health Science Center at San Antonio
Not applicableStudy completedNCT03581552
What this trial is testing

Effects of Aromatase Inhibitor Therapy on Muscle Function

Who this might be right for
Breast CancerBreast Cancer Female
Tarah J Ballinger, MD 16
Not applicableStudy completedNCT00399321
What this trial is testing

A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer

Who this might be right for
Postmenopausal Bone LossBreast Cancer
University of Michigan Rogel Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT02273973
What this trial is testing

Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)

Who this might be right for
Breast Cancer
Genentech, Inc. 334
Not applicableLooking for participantsNCT06610565
What this trial is testing

Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast Cancer

Who this might be right for
Breast Cancer
European Institute of Oncology 60
Large-scale testing (Phase 3)Study completedNCT00286117
What this trial is testing

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

Who this might be right for
Breast Cancer
AstraZeneca 448
Early research (Phase 1)Study completedNCT02154776
What this trial is testing

Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.

Who this might be right for
Advanced or Metastatic Breast Cancer
Novartis Pharmaceuticals 13
Not applicableStudy completedNCT01951976
What this trial is testing

Yoga for Aromatase Inhibitor-associated Joint Pain

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 16
Large-scale testing (Phase 3)Study completedNCT00673335
What this trial is testing

Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
UNICANCER 170
Testing effectiveness (Phase 2)Study completedNCT00238290
What this trial is testing

Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer

Who this might be right for
Breast Cancer
Swiss Cancer Institute 13
Early research (Phase 1)Active Not RecruitingNCT06315205
What this trial is testing

Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women

Who this might be right for
Healthy
Rovi Pharmaceuticals Laboratories 90
Not applicableStudy completedNCT01461070
What this trial is testing

Intestine Bacteria and Breast Cancer Risk

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 175
Load More Results